Middle East Home Healthcare Market Trends, Growth, and Forecast 2026-2034
Market Overview
The Middle East home healthcare market size reached USD 19,951.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 33,841.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.05% during 2026-2034. Factors such as the region’s aging population, advancements in telehealth technology, and supportive government policies promoting personalized, cost-effective care at home are driving this growth. Home healthcare delivers tailored medical services by skilled professionals within patients’ homes, offering both physical and emotional benefits.
How AI is Reshaping the Future of Middle East Home Healthcare Market
Adoption of AI-powered remote monitoring systems is enhancing patient care accuracy and reducing hospital readmissions.
Government initiatives in the Middle East are increasingly funding smart home healthcare solutions to improve accessibility.
AI-driven predictive analytics help healthcare providers anticipate patient deterioration, optimizing intervention timing.
Companies in the region are launching AI-enabled telehealth platforms for continuous chronic disease management.
Natural language processing based virtual health assistants are improving patient engagement and medication adherence.
Grab a sample PDF of this report: https://www.imarcgroup.com/middle-east-home-healthcare-market/requestsample
Market Growth Factors
The rising prevalence of chronic conditions such as diabetes, cardiovascular disorders, and respiratory illnesses, combined with a steadily aging population across the Middle East, is significantly increasing demand for continuous medical support delivered outside traditional hospital settings. Patients and families increasingly prefer care in the familiar comfort of home, which improves quality of life, reduces the strain on overcrowded facilities, and supports long-term management of complex health needs through personalized nursing, therapy, and daily assistance services.
Technological progress is transforming home healthcare delivery throughout the region. Remote patient monitoring systems, wearable devices, telemedicine platforms, and digital health applications enable real-time tracking of vital signs, virtual consultations, and timely clinical interventions. These innovations expand access to specialist care, particularly in urbanizing Gulf nations, enhance medication adherence, lower hospital readmission risks, and allow multidisciplinary teams to coordinate treatment effectively while patients remain at home.
Supportive government policies and strategic healthcare reforms are accelerating the shift toward home-based models. Initiatives promoting patient-centered care, privatization of services, expanded insurance coverage for domiciliary treatment, and investments in digital infrastructure encourage providers to develop comprehensive in-home offerings. Growing awareness of the convenience and efficiency of home healthcare further drives adoption as an accessible alternative that eases pressure on conventional medical institutions.
Market Segmentation
Product:
Therapeutic Products
Testing, Screening, and Monitoring Products
Mobility Care Products
Service:
Skilled Nursing
Rehabilitation Therapy
Hospice and Palliative Care
Unskilled Care
Respiratory Therapy
Infusion Therapy
Pregnancy Care
Indication:
Cancer
Respiratory Diseases
Movement Disorders
Cardiovascular Diseases and Hypertension
Pregnancy
Wound Care
Diabetes
Hearing Disorders
Others
Country:
Saudi Arabia
Turkey
Israel
United Arab Emirates
Iran
Iraq
Qatar
Kuwait
Oman
Jordan
Bahrain
Others
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Recent Development & News
August 2026: Kuwait expands home healthcare across all governorates via multidisciplinary teams of doctors, nurses, physiotherapists and pharmacists, delivering advanced nursing care such as chronic bedsore treatment, post-surgical wound management and home safety assessments to free hospital beds.
July 2026: Bupa CareConnect in Saudi Arabia reports digital consultations growing more than fivefold, integrating home laboratory testing through partnerships like Al Borg Diagnostics, direct medication delivery and AI-powered remote monitoring for chronic care management.
June 2026: The Saudi Food and Drug Authority grants the world’s first marketing authorization for an AI-powered smartphone app using remote photoplethysmography technology to measure heart rate, oxygen saturation and blood pressure from a short facial video, enabling contactless home vital-sign tracking.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
Comments